Home  Home | Contact us | How to find us | News | Accessibility
A member of Cambridge University Health Partners - www.cuhp.org.uk

Dr Uta HillDr Uta Hill

Consultant Physician

Contact Details
Switchboard: 01480 830541
Fax: 01480 831315

Amy Blowers
Tel: 01480 364477
Email amy.blowers1@nhs.net

Respiratory Medicine, General Internal Medicine

Specialist Clinical Interests
Cystic Fibrosis
Complex lung infections
Non-tuberculous mycobacterial disease
Fungal disease
Primary Ciliary Dyskinesia

Research Interests
Neutrophil migration and function
Immune responses to vaccination
Immune responses in cystic fibrosis
Non-tuberculous mycobacterial disease in cystic fibrosis

Professional Profile
Uta Hill graduated from the combined MB/PhD programme at the University of Cambridge in 2003, having completed a PhD in vaccine research and her medical training.

She then worked predominantly in East Anglia and undertook specialist training in general and respiratory medicine on the Eastern Deanery Rotation Programme.

From 2010 to 2011, Dr Hill gained a Cystic Fibrosis Trust Clinical Fellowship at Papworth Hospital. She completed her specialist training in 2014.

Since February 2014, she has been working in the Cambridge Centre for Lung Infection at Papworth Hospital as Locum Consultant initially and is now as a Consultant. 

Education and Training
2003 MB/BChirg    University of Cambridge
2003 PhD               University of Cambridge
2006 MRCP
2012 Fellow of Higher Education Academy
2014 CCST  Respiratory and General Internal Medicine

Current membership(s) of professional, national and regional bodies and university posts
Member, Royal College of Physicians
Member, British Thoracic Society

Recent and Important Publications
U. G. Hill, C. R. Sander, Advances in TB vaccinology,  Current Respiratory Reviews 2013.

U. G. Hill, R.A. Floto, C. S. Haworth. Non-tuberculous mycobacterial disease in cystic fibrosis. Royal Society of Medicine Journal 2012.

C. B. Stober, U. G. Lange, M. T. M. Roberts, A. Alcami, and J. M. Blackwell. Heterologous Priming-Boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c mice. Infection and Immunity 2007, 75:852-860.

C. B. Stober, U. G. Lange, M. T. M. Roberts, B. Gilmartin, B. Francis, C. Peacock, S. McCann and J. M.
Blackwell. From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine 2006, 24:2602-16.

C. B. Stober, U. G. Lange, M. T. M. Roberts, A. Alcami and J. M. Blackwell. IL-10 from CD4+CD25+ regulatory T cells determines vaccine efficacy in murine Leishmania major infection. Journal of Immunology 2005, 175:2517-24.

U. G. Lange, P. Mastroni, J. M. Blackwell and C. B. Stober. DNA-Salmonella enterica Serovar Typhimurium Primer-Booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major
infection in mice. Infection and Immunity 2004, 72:4924-8.